Abbott Laboratories
ABT: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| r<p | LOCK|@#N? | LOCK|$?qm>>! |
Abbott Earnings: Pockets of Strength More Than Offset Areas of Softness
Abbott's third-quarter results included reported revenue growth of 7%, with US nutrition sales falling 7% and global device revenue up 15% year over year.
